Thank you for supporting the #ACSgivesback campaign. We are happy to share ACS employees contributed $755, which was matched by ACS for a total of $1,510 contributed to the Emory COVID-19 Impact Fund.

Over the last five months, Emory has worked tirelessly to research and understand the novel coronavirus. We have learned how to care for patients more effectively with new treatments and protocols. We have discovered ways to protect ourselves and worked to educate our community on the measures of masking, social distancing, washing hands routinely, and monitoring our wellness to help stop the spread of this disease.

Thanks to your support of the Emory COVID-19 Impact Fund, Emory has been able to care for patients—and their families—by furnishing more than 300 baby monitors, purchased to allow immobile ICU patients to communicate with family. This fund also allowed Emory Healthcare to purchase 50 critical care ventilators, as well as cutting-edge technology like eICU carts and telemedicine tablets to provide additional layers of critical care service.

Emory researchers are at the forefront of COVID-19 discovery, and this fund has supported critical success stories like these:

• COVID-19 vaccine tested at Emory is safe, generates immune response, early results show 
• Lung radiation helps coronavirus pneumonia patients recover faster, study says 
• Repurposing a cancer drug to reduce COVID-19 lung inflammation
• Phase 3 COVID-19 vaccine trials will begin soon, and volunteers are needed

Thank you for your gift to the COVID-19 Impact Fund. Your generosity helps make this progress possible. Even though this campaign has ended, you can still share the opportunity to give to the COVID-19 Impact Fund through this link.

No one can put it more succinctly than one of our patients who recently shared, “When the world shut down, Emory was still there. I feel honored to be a part of Emory’s community."